The Role of Scintigraphy with Technetium-99m Nanocolloid in Patients with Peripheral Joint Pain


We studied 51 patients with peripheral joint pain to assess the ability of technetium-99m-nanocolloid (99mTc NC) scintigraphy to distinguish patients with active joint disease from those without, irrespective of their underlying aetiology. Patients with peripheral joint pain due to various causes were clinically categorised as either having objective signs… (More)
DOI: 10.1007/s100670170039


3 Figures and Tables